|
|||||||
| Forum | Register | Calendar | Search | Today's Posts | Mark Forums Read |
![]() |
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
.Ingen Unveils the New SMART Nasal Cannula at Alpha-1
Ingen at the Alpha-1 Association National Conference in Orlando, Florida Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes Symbol Price Change IGNT.PK 0.0004 0.0000 {"s" : "ignt.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Monday June 14, 2010, 8:15 am Ingen Technologies, Inc. (IGNT), Manufacturer of the New SMART Nasal Cannula for the Home Care Provider Market and Hospital Market, is Featured Side-by-Side Mid and Large Cap Companies Such as Baxter (BAX) at the Alpha-1 19th Annual National Education Conference YUCAIPA, Calif., June 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, unveiled their new SMART Nasal Cannula in Orlando-Florida last week at the Alpha-1 19th Annual National Education Conference. The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research. Alpha-1-Antitrypsin Deficiency (Alpha-1) is a genetic disorder that can cause liver and lung disease in children and adults. "We were very pleased to be an exhibitor and sponsor at this year's conference for Alpha-1. There are hundreds of patient members of the Alpha-1 Association, and many of them attended the conference, along with clinicians and physicians from around the globe. Our new SMART Nasal Cannula was featured and well accepted by the attendees. It is our goal to pick up the pace in supporting the various associations that support patients who require home oxygen therapy and the use of our products," stated Scott R. Sand, CEO and Chairman of the Board. Alpha-1 Association Ingen Tech SMART NASAL CANNULA with Oxyview Technology - Home - Yucaipa, CA 92399, CA Pulse Oximeter - Home - Yucaipa, CA 92399, CA About Ingen: Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacturer representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters. The Ingen Technologies, Inc. logo is available at GlobeNewswire, Inc. |
|
|||
|
Ingen Unveils the New SMART Nasal Cannula at Alpha-1
Ingen at the Alpha-1 Association National Conference in Orlando, Florida Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes Symbol Price Change IGNT.PK 0.0004 0.0000 {"s" : "ignt.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Monday June 14, 2010, 8:15 am Ingen Technologies, Inc. (IGNT), Manufacturer of the New SMART Nasal Cannula for the Home Care Provider Market and Hospital Market, is Featured Side-by-Side Mid and Large Cap Companies Such as Baxter (BAX) at the Alpha-1 19th Annual National Education Conference YUCAIPA, Calif., June 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S. and $8 billion globally, unveiled their new SMART Nasal Cannula in Orlando-Florida last week at the Alpha-1 19th Annual National Education Conference. The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research. Alpha-1-Antitrypsin Deficiency (Alpha-1) is a genetic disorder that can cause liver and lung disease in children and adults. "We were very pleased to be an exhibitor and sponsor at this year's conference for Alpha-1. There are hundreds of patient members of the Alpha-1 Association, and many of them attended the conference, along with clinicians and physicians from around the globe. Our new SMART Nasal Cannula was featured and well accepted by the attendees. It is our goal to pick up the pace in supporting the various associations that support patients who require home oxygen therapy and the use of our products," stated Scott R. Sand, CEO and Chairman of the Board. Alpha-1 Association Ingen Tech SMART NASAL CANNULA with Oxyview Technology - Home - Yucaipa, CA 92399, CA Pulse Oximeter - Home - Yucaipa, CA 92399, CA |
|
|||
|
News out on this one again this morning. Awesome volume coming in on this one today. I expect to see alot more from the company this week and weeks to come. Were at a great entry point here. There is rumors of the company announcing contracts after the bell. Hope to see that one hit the wire soon. Good luck to you all
|
|
|||
|
Ingen Scheduled for Medtrade-Atlanta
Management and Consulting Partners Pushing Hard to Meet $11M Projected Sales Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes Symbol Price Change IGNT.PK 0.0004 +0.0001 {"s" : "ignt.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Friday June 18, 2010, 5:00 pm EDT YUCAIPA, Calif., June 18, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a medical device manufacturer with an emerging new medical product line for the $8B respiratory market, announced today that the company has officially accepted to be an exhibitor and sponsor at the upcoming Medtrade conference in Atlanta, Georgia from November 15-18, 2010 at the Georgia World Congress Center. The Home Medical Equipment industry is constantly evolving, but one thing remains the same -- the demand for the latest products and technology will be at Medtrade where thousands of qualified attendees will be there to buy the products and services that are right for their customers, and that will ensure the success of their business. Ingen will introduce the new IngenThermo drug product, as well as their Oxyview product line and SMART Nasal Cannula. The company plans to seize this great opportunity to take advantage of all Medtrade has to offer. The company will showcase its products and services, and create new alliances. "We are focused on product sales and marketing. Our tradeshow attendance will double this year in order to brand our products. We look forward to a very successful and prosperous fiscal year 2010," stated Scott R. Sand, CEO and Chairman of the Board. About Medtrade Ingen Tech SMART NASAL CANNULA with Oxyview Technology - Home - Yucaipa, CA 92399, CA Pulse Oximeter - Home - Yucaipa, CA 92399, CA About Ingen: Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters. |
|
|||
|
An online newsletter that has made thousands of dollars in profit for its readers – is committed to uncovering you potentially explosive stocks that are leading the market.
pennyalerts.info |
![]() |
| Thread Tools | |
| Display Modes | |
All times are GMT. The time now is 05:54 AM.
ITalkCash.com - Forum for financial investments - Archive - Top
All rights reserved www.italkcash.com